BioNeutra Global Stock

BioNeutra Global Equity

The The Equity of BioNeutra Global (BGA.V) as of Aug 23, 2026 is -6.19 M CAD. In the previous year, The Equity was -3.76 M CAD — a change of 64.92% (lower).

Equity

-6.19 MCAD

YoY

64.92%

Last updated:

In 2026, BioNeutra Global's equity was -6.19 M CAD, a 64.92% increase from the -3.76 M CAD equity in the previous year.

The BioNeutra Global Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2016
15.78 M CAD
Jan 1, 2017
13.96 M CAD
Jan 1, 2018
18.06 M CAD
Jan 1, 2019
4.75 M CAD
Jan 1, 2020
700,900.00 CAD
Jan 1, 2021
-1.03 M CAD
Jan 1, 2022
-3.76 M CAD
Jan 1, 2023
-6.19 M CAD
The BioNeutra Global Equity history
YEAREquityYoY
-6.19 MCAD+64.92%
-3.76 MCAD+263.27%
-1.03 MCAD-247.51%
700,900.00CAD-85.25%
4.75 MCAD-73.68%
18.06 MCAD+29.39%
13.96 MCAD-11.57%
15.78 MCAD+3.93%
15.19 MCAD+42.76%
10.64 MCAD—
Access this data via the Eulerpool API
Get Free API Key

BioNeutra Global Stock analysis

What does BioNeutra Global do? BioNeutra Global is one of the most popular companies on Eulerpool.

Equity Details

Analyzing BioNeutra Global's Equity

BioNeutra Global's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding BioNeutra Global's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating BioNeutra Global's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

BioNeutra Global's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in BioNeutra Global’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about BioNeutra Global stock

The Equity of BioNeutra Global is -6.19 M CAD in 2026.

The Equity of BioNeutra Global changed from -3.76 M CAD to -6.19 M CAD, representing a 64.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity BioNeutra Global since 2006 – with annual values, charts, and detailed analysis.

The Equity's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's BioNeutra Global historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — BioNeutra Global

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — BioNeutra Global